Sentences with phrase «with pharma companies»

«And we are actively involved in cooperation with pharma companies, university institutions, private laboratories, and technology providers,» Geppert says.

The HHS secretary went on to say that his agency wanted to find ways for Medicaid and Medicare to bring drug prices down by creating more resources to negotiate with pharma companies.

The California Medical Association, which represents doctors in California, opposes the measure because of that claim, and also because the group said the cancellation of drug purchasing contracts the state already has with pharma companies «would remove many drugs from the Medi - Cal list of pre-approved medicines — creating a new prior authorization hurdle for patients and their physicians.»

Insurers have been striking deals with pharma companies that will land them discounts on pricey drugs if those treatments don't demonstrably improve patients» health outcomes; hospitals are penalized if they have high rates of patient readmissions.

Brave new partnerships will emerge — a food and beverage brand will join forces with a pharma company to master the regulatory climate.

These gatekeepers don't always get it right but they have a huge incentive to because they get the blame (along with the pharma company) for errors.

Not exact matches

While the early - stage company still mounted losses for the quarter, it received more revenue than expected as a result of its collaboration with pharma giant Pfizer.

-- Ahmed Albaiti, founder and CEO of Medullan, a digital health innovation company that works with payers, providers, and pharma on patient engagement.

But the initiative comes with another huge financial prize for firms that successfully win FDA approval for these niche therapies: a priority review voucher that can be used to slash the regulatory period for a different experimental specialty treatment being developed by a drug maker or, more often, sold for potentially hundreds of millions of dollars to another pharma company.

Big biotech and pharma companies are absolutely dependent on being able to successfully innovate by partnering with and acquiring disruptive startups because of the nature of the patent cliff in pharmaceuticals.

She speculates that the company strengthened its bonds with customers by taking a stand against Big Pharma.

Fortune spoke with 25 - year pharmaceutical vet Ramona Sequeira, president of Takeda's U.S. business unit since 2015, on the challenges of adapting an international pharma company to the U.S. healthcare and reimbursement system and the firm's America - centric business plans.

President Donald Trump sat down with a host of major pharma company CEOs Tuesday morning to address pressing issues like high drug prices, the future of the FDA, and where treatments are produced.

With few competitors on the market, the pharma company reportedly planned on even steeper hikes to the price, figuring that a combination of customers» insurance coverage and discounts the company provides to patients would offset the increases.

The report points to a number of factors driving big pharma companies» struggles with netting strong returns, including a dearth of late - stage pipeline candidates and diversified product portfolios that aren't necessarily spreading risk.

Rather than competing with the largest pharma companies in the world, she'd be competing with only a few academic groups.

Say you're a pharma company with a key product which brings in about $ 1.49 billion in annual sales, or a little less than 10 % of your revenue stream.

At one time blocked by the FDA, 23 & Me is now a smash hit with both consumers and pharma companies.

By printing multiple lung airways — or any other afflicted organ — from a human patient and testing drugs on them, pharma companies can bypass the ethically challenged practice of testing on animals and proceed to human clinical trials with greater confidence the drugs will actually work, according to Wadsworth.

Biotech giant Gilead Sciences is beefing up its cancer drug portfolio with a $ 11.9 billion deal to buy Kite Pharma, a company focused on a groundbreaking new class of treatments that turns the body's own immune cells into targeted blood cancer killers.

The intense, full - day strategy sessions invariably ended with Cornelius getting a headache, he says — particularly when he sparred with executives in the company who clung to vestiges of big, fat pharma.

Jazz said in a filing that it did so in response to the overall takeover environment for pharma companies and in light of a patent litigation settlement that allows Hikma Pharmaceuticals to sell a generic version of Xyrem with Jazz receiving royalty payments on those sales.

Immuno - oncolocy has been the focus of Big Pharma and biotechs alike, with companies such as Merck (mrk), Bristol - Myers Squibb (bmy), Pfizer (pfe), Roche / Genentech, Juno (juno), Kite Pharma (kite), Novartis (nvs), and countless others pouring massive investments into the space (the Loncar ETF contains almost all of these companies).

A Reuters report citing sources who say that the firm is in talks with investment backs after being approached by several pharma companies for a buyout.

The premiums that pharma companies pay for biotechs with mid-to-late stage experimental drugs has risen to a point that has some analysts crying «bubble.»

Kite Pharma, Juno Therapeutics, and Bluebird Bio are among a growing group of biotech companies working with CAR - T.

The race to become the first company with a chimeric antigen receptor T - cell (CAR - T) cancer therapy on the market has entered its final leg, and Kite Pharma now appears to have a big advantage.

Ironwood Pharma May Satisfy Activist Denner with Split - up Plan, but He Still Seeks Board Seat (CNBC) Ironwood Pharmaceuticals» stock rose Tuesday after the company said...

Fortune Brainstorm Health, in association with IBM Watson Health, gathers not only C - suite leaders of top companies, hospitals, insurers, and cutting - edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care.

And big players like J&J have been successful in stalling the competition through a framework of deals with the companies managing pharma benefits in the US.

In a recent interview with The Hill, Ubl said that he understands why Trump is pointing to pharma companies regarding high drug prices.

With sustainable, plant - based ingredients and unique, advanced facilities, the Science People at Roquette develop solutions for companies of any size, enabling business partners to excel in their respective product categories: human nutrition, animal nutrition, pharma, and biochemical.

Tim Sykes spoke to Tiziano Petrucciani, quality & technical development director at Molteni Farmaceutici, the renowned Italian specialist in pharma R&D and production, about the company's collaboration with Rockwell Automation, using serialisation as a springboard for a profound modernisation of its manufacturing processes.

Suffolk County is suing Connecticut - based Purdue Pharma along with a number of other pharmaceutical companies for deceptive practices that it claims led to the county's opioid and heroin epidemic.

She participated in collaborations with small biotech companies and big pharma.

Recognizing a growing niche for outsourcing services, McElroy launched The Research Network, which today gathers several dozen former pharma employees into a firm that helps companies work with contract research organizations.

IN TODAY»S biotech industry, start - up companies sprout from every university biology department, looking to hook up with big pharma or agrochemical firms to take their patented, DNA - based ingenuity lucratively to market.

We are in touch with the Austrian Academy of Sciences, the Federal Ministry of Education and Research, various public and private institutions and agencies, various Viennese universities, numerous biotech and pharma companies, biotech consultancies, and international student clubs that share Club Biotech's visions and goals.

Once they are out of university, «we are more likely to recruit those with work experience in the small - molecule field, often from pharma companies,» she says.

The space isn't only confined to pharma either, as science company DuPont also formed alliances with Lithuania's Vilnius University and Caribou Biosciences, with a specific interest in plant breeding and agricultural applications.

«The acquisitions within the pharma industry are symptomatic of many companies with relatively weak pipelines that are acquiring innovation by consolidating with larger companies to reduce expenses.»

«These findings could allow the pharma companies to open up large libraries of potent drug candidates earlier discarded due to solubility problems and try them again together with Upsalite,» says Maria Strømme, Professor at the Division of Nanotechnology and Functional Materials at Uppsala University.

Roughly three - quarters of respondents work in private industry, with 47 percent employed by biotechnology companies, 33 percent in pharmas, and the remaining 20 percent in biopharmas.

Like other big pharma companies, Pfizer is partnering with academic institutions to share the risk of drug development and take advantage of academic scientists» broad base of knowledge, says Boston - based Anthony Coyle, vice president of the Centers for Therapeutic Innovation (CTI) at Pfizer.

Another area that big pharma has traditionally been reluctant to get involved with is research into orphan diseases — ones that affect so few people that working on them is not usually considered commercially viable by large companies.

Fixing the market failure in antibiotics production means transforming pharma companies — or parts of them — into public goods producers, with public interest rather than profit driving R&D and marketing.

Last July, Novartis Pharma admitted that a former employee created a conflict of interest by participating in clinical studies of valsartan, sold under the trade name Diovan, conducted by five Japanese medical schools while concealing his affiliation with the company.

Hayward could not be specific about the cost of the technique but he says it would not affect the final price of a drug — it is «quite affordable» even for textile companies that are not as flush with cash as the pharma giants.

In the race to develop an Ebola vaccine, a small cancer therapy company, NewLink Genetics, has been in the shadows of GlaxoSmithKline (GSK), a big pharma company with lots of experience and far deeper resources.

They have joined forces with CHS Pharma, Inc., a South Florida - based biotechnology development company that has an intellectual property portfolio for potential treatments related to ischemic stroke, dry macular degeneration as well as other age - related disorders such as Alzheimer's disease, to further develop and commercialize this promising technology.